Posts by: Aisha I Abdullah PhD

Aisha I Abdullah PhD

Aisha Abdullah received a B.S. in biology from the University of Houston and a Ph.D. in neuroscience from Weill Cornell Medical College, where she studied the role of microRNA in embryonic and early postnatal brain development. Since finishing graduate school, she has worked as a science communicator making science accessible to broad audiences.

December 17, 2020December 17, 2020

JIA Patients Show Differences That May Affect Future Disease Activity, Study Says

News

An analysis using machine learning identified distinct patient groups and disease activity trajectories among young patients in the U.K. with juvenile idiopathic arthritis ... Read more

December 10, 2020December 10, 2020

Genome Analysis Identifies New JIA-linked Genetic Variants, Targets

News

A large-scale genome analysis has identified five genetic variants newly associated with disease susceptibility in multiple subtypes of juvenile idiopathic arthritis ... Read more

November 5, 2020November 5, 2020

Epstein-Barr Increases JIA Disease Activity, Impairs Treatment Response, Study Finds

News

Previous Epstein-Barr virus (EBV) infection is associated with increased disease activity and impaired response to treatment in children with juvenile idiopathic arthritis (JIA), a ... Read more

October 15, 2020October 15, 2020

Gene Variants May Predict Adverse MTX Treatment Outcome in JIA Patients

News

Variations in single nucleotides — the building blocks of DNA — in two genes may help predict the safety and efficacy ... Read more

September 17, 2020September 17, 2020

Brenzys, Biosimilar to Enbrel, Approved to Treat JIA in Canada

News

Health Canada has expanded the approved use of Brenzys, a biosimilar of Enbrel (etanercept), to include the treatment of juvenile idiopathic arthritis ... Read more